After 131I treatment in NPC hNIS-transfected cells, the levels of P53, activated Caspase-3, and Survivin proteins were increased, but Bcl-2 protein was decreased compared to the control group. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.